Cargando…
Repurposing approved drugs on the pathway to novel therapies
The time and cost of developing new drugs have led many groups to limit their search for therapeutics to compounds that have previously been approved for human use. Many “repurposed” drugs, such as derivatives of thalidomide, antibiotics, and antivirals have had clinical success in treatment areas w...
Autor principal: | Schein, Catherine H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018532/ https://www.ncbi.nlm.nih.gov/pubmed/31432544 http://dx.doi.org/10.1002/med.21627 |
Ejemplares similares
-
Repurposing approved drugs for cancer therapy
por: Schein, Catherine H
Publicado: (2021) -
Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016) -
Repurposing FDA-approved drugs for anti-aging therapies
por: Snell, Terry W., et al.
Publicado: (2016) -
Repurposing clinically approved cephalosporins for tuberculosis therapy
por: Ramón-García, Santiago, et al.
Publicado: (2016) -
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
por: Jones, Dylan, et al.
Publicado: (2022)